“Reconciliations of net income attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility are presented in the tables below: 52 Table of Contents (In thousands of U.S.”10-Q · Apr 30, 2026 ↗
IMAX Corporation
IMAX
Market read
IMAX Corporation's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.
- IMAX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if IMAX's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- IMAX's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +16.5% year over year.
- Operating margin changed +8.1 percentage points in the latest annual period.
- Net margin changed +1.1 percentage points in the latest annual period.
- Operating cash flow covered net income at 3.64x in the latest annual period.
- Diluted shares increased 3.1% in the latest annual period.
- Credit and interest rates has repeated adverse evidence across 4 filings.
- Foreign exchange has repeated adverse evidence across 4 filings.
- Restructuring and cost reductions has repeated adverse evidence across 4 filings.
- Labor availability and costs has repeated adverse evidence across 3 filings.
- P/E is 172% above the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 163% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 10, 2026
51.31Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“For the three months ended March 31, 2026, the Company recorded a foreign exchange net loss of $0.6 million, resulting from changes in exchange rates related to foreign currency denominated monetary assets and liabilities (2025 — net loss of $0.4 million).”10-Q · Apr 30, 2026 ↗
“The impairment charge was due to a change in the Company’s market focus, resulting in a downward adjustment to the SSIMWAVE reporting unit’s expected cash flows based on the discounted cash flow method.”10-K · Feb 25, 2026 ↗
“Year-over-year the benefits of the Employee Retention Credit are partially offset by adjustments recorded in the prior year relating to payouts in connection with a prior year acquisition.”10-K · Feb 25, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 6.9× · EV/sales 6.6×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for IMAX. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for IMAX. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind IMAX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SONYSony Group CorporationpartnerApr 30, 2026 ▾
“The Machine Comes Alive, and with Sony Pictures for the two-night-only screening of TOMMY in IMAX (50th Anniversary) .”
AMZNAmazon.com, Inc.customerOct 23, 2025 ▾
“These increases in revenue due to higher box office were partially offset by the revenue earned from the completion of the sale of the worldwide commercial and streaming rights of the Company’s original documentary, The Blue Angels , to Amazon Content recorde…”
Depended on by
AMCAMC Entertainment Holdings, Inc.partnerFeb 23, 2026 ▾
“A-List also includes premium offerings including IMAX ® , Dolby Cinema™ at AMC, RealD, Prime and other PLF brands.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
IMAX is currently a Early Follower in the organic co-movement group Shared Infrastructure Providers. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for IMAX; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.